Day One: Monday, June 1, 2026 - ET (Eastern Time, GMT-05:00)
- Learn about the capabilities ethics and compliance officers require to navigate the evolving ethical climate and standards
- Explore the leadership opportunities for ethics and compliance officers and the strategies to achieve and maintain success
- Examine the latest national enforcement priorities and how emerging regulatory expectations are shaping compliance oversight and organizational risk
- Explore global enforcement developments and policy shifts, including the impact on multinational compliance operations and cross‑border decision‑making
- Identify actionable strategies to adapt compliance frameworks, strengthen monitoring, and anticipate how national and international trends may influence enforcement in the years ahead
- Hear the latest strategic updates from IMC and MedTech for 2026–2027, including a focus on the associations’ evolving priorities
- Understand how Legal, Ethics and Compliance professionals can contribute to the 2026-2027 objectives
- Specialty pharmacy plays a critical role in shaping delivering patient support programs. Explore the latest regulations, case law and provincial variations impacting compliance and care delivery
- Understand how the pharmaceutical industry coexists with specialty pharmacies and the challenges this brings
- Address the role of digital assets in PSPs, their potential to enhance patient engagement, and the challenges they pose
- Annie Bourgault - President, Integrated Pharma Services, Inc.
- Brigitte Viel - Executive Director, Regroupement des Pharmacies de Médicaments de Spécialité du Québec
- Randy Levitt, PhD - Director, Pharmacovigilance, Medical Information & Patient Support, Knight Therapeutics Canada
- Laura Weinrib - Partner, Blakes
As a follow up to the 2025 edition, this extended practical session will work through new hypothetical case study scenarios using audience participation to identify key decisions points and indicators of risk and solutions
- Develop a comprehensive understanding of the legal and regulatory framework governing OLAs, including key regulations, enforcement trends, and guidance documents
- Gain advanced insights and hone practical skills in OLA governance, emphasizing adherence to the latest regulations and industry best practices through industry case studies
- Enhance your ability to identify and mitigate compliance risks associated with OLA programs by working through new scenarios
- Derek Frueh - Head of North American Compliance, Canadian General Counsel, Leo Pharma
- Maria Daher Khouri - Head of Ethics and Business Integrity (EBI) Canada, Sanofi
- Jennifer Carroll - Director of Technology and Collaborative Innovation, Pharmaceutical Advertising Advisory Board (PAAB)
- Tania Alexander - Director, Centre of Excellence – Medical Education, AstraZeneca Canada
In this roundtable format, participants will break into small, facilitated groups to discuss real‑world challenges and compare organizational approaches in an interactive, peer‑driven setting. Each table will focus on one core theme—commercial models, pricing strategies, or compliance considerations—with a rotating structure that enables attendees to contribute to multiple discussions. Facilitators will guide conversation flow, capture key insights, and encourage the exchange of practical tactics, ensuring that every participant leaves with actionable takeaways and a deeper understanding of how other MedTech organizations are navigating similar issues.
- Navigate innovative go‑to‑market strategies for high‑priced capital equipment, including product placement agreements and value‑add offerings
- Address compliance, antitrust, and pricing‑model considerations in emerging commercial approaches
- Manage RFP responses for health bodies while aligning cross‑functional teams to meet regulatory and procurement requirements
- Jessica Greco - Senior Manager Health Care Compliance, Johnson & Johnson MedTech
- Examine how compliant social media tactics influence decision‑making, audience engagement, and overall communication within Canadian ASC and PAAB standards
- Practical approaches when reviewing social media campaigns to ensure transparent, responsible, and audience‑focused messaging whilst meeting ethical and regulatory expectations for accuracy, balance, and credibility
- Kathy Brennan - Compliance Business Partner, Roche
- Laura Pietrantonio - Lawyer, LJT Avocats Lawyers
- Lama Abi Khaled - Executive Director, Ethics, Legal & Regulatory, Innovative Medicines Canada
- Practical approaches to design coordinated HCP engagement models that ensure compliant, accurate, and aligned communication across all touchpoints
- Identify common challenges and explore innovative strategies to maximize collaboration effectively while ensuring compliance
- Leverage advanced tools and workflows to deliver reliable, transparent, and audit‑ready interactions with HCPs
- Lisa Noble - Ethics and Compliance Lead, North America, Bausch & Lomb
This practical session will work through hypothetical case study scenarios that are common in the Pharmaceutical and Medical Technology industries, using audience participation to identify key decisions points and indicators of risk and solutions
- Examining the evolving roles, responsibilities, and compliance boundaries across organizations
- Areas of risk: how do you guard against potential kickbacks and improper incentives?
- Should compliance monitor these relationships and how?
- Karen Southin - Ethics and Compliance Officer, Pharmacosmos
- Derek Frueh - Head of North American Compliance, Canadian General Counsel, Leo Pharma
- Luciana Andrade - Sr. Manager Corporate Counsel, Edwards Lifesciences
- Tania Alexander - Director, Centre of Excellence – Medical Education, AstraZeneca Canada
- Gabriella Ekmekjian - Compliance Officer, Medtronic
